Clinical trials
Phase 4 Lymphoma trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
35 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2004 | 2 |
| 2005 | 1 |
| 2006 | 1 |
| 2007 | 1 |
| 2009 | 2 |
| 2012 | 1 |
| 2013 | 5 |
| 2014 | 3 |
| 2015 | 5 |
| 2016 | 3 |
| 2020 | 1 |
| 2022 | 3 |
| 2023 | 1 |
| 2024 | 2 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 16 |
| Unknown status | 13 |
| Recruiting | 3 |
| Active, not recruiting | 1 |
| Terminated | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Peking University | 7 |
| Sanofi | 2 |
| Takeda | 2 |
| Azienda Ospedaliero, Universitaria Ospedali Riuniti | 1 |
| CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. | 1 |
| Centre Hospitalier Universitaire, Amiens | 1 |
| Children's Hospital of Michigan | 1 |
| Chongqing University Cancer Hospital | 1 |
| Christine Mauz-Körholz | 1 |
| Dana-Farber Cancer Institute | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lymphoma | 35 |
| Leukemia | 5 |
| Hodgkin Disease | 4 |
| Recurrence | 4 |
| Hematologic Diseases | 3 |
| Hepatitis B | 3 |
| Lymphoma, Non-Hodgkin | 3 |
| Neoplasms, Plasma Cell | 3 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 3 |
| Anemia | 2 |
Trials
Showing 51 to 35 of 35. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.